Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Hemodynamic Stability in Pheochromocytoma Surgery
NCT06037135Completed
- Sponsor
- Yonsei University
- Start
- Dec 2012
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in pheochromocytoma (2 arms), sponsored by Yonsei University. Primary endpoints: Maximum Intraoperative Blood Pressure (SBP, DBP, MBP), Duration of SBP Increase by 30% or More From Baseline and 4 more. Started Dec 2012; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
pheochromocytoma
Beyond the preview
Go deeper on NCT06037135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06037135.